Overview
- At the formal inauguration, the company confirmed it now occupies nine floors—about 60% of the refurbished Edificio Estel.
- Around 1,600 staff have relocated to the site, with staffing targeted at roughly 2,000 by year‑end and plans to grow beyond that as space expands to 30,000 m² next year.
- AstraZeneca reaffirmed €1.3 billion in investment through 2027 for a digital hub with no wet labs, including about 400 specialists dedicated to artificial intelligence.
- Executives now cite 450 research projects and 259 clinical trials underway, indicating growth from earlier reported totals.
- Research is concentrated in cancer (60% of studies), with cardiovascular (13%) and respiratory (10%) also key, as national and regional leaders attended the opening.